annual EBITDA:
-$238.09M-$69.63M(-41.33%)Summary
- As of today (June 18, 2025), RYTM annual EBITDA is -$238.09 million, with the most recent change of -$69.63 million (-41.33%) on December 31, 2024.
- During the last 3 years, RYTM annual EBITDA has fallen by -$169.64 million (-247.81%).
- RYTM annual EBITDA is now -2151.87% below its all-time high of -$10.57 million, reached on December 31, 2015.
Performance
RYTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$43.63M-$6.07M(-16.17%)Summary
- As of today (June 18, 2025), RYTM quarterly EBITDA is -$43.63 million, with the most recent change of -$6.07 million (-16.17%) on March 31, 2025.
- Over the past year, RYTM quarterly EBITDA has increased by +$92.29 million (+67.90%).
- RYTM quarterly EBITDA is now -588.65% below its all-time high of -$6.33 million, reached on March 31, 2017.
Performance
RYTM quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$146.32M+$92.29M(+38.68%)Summary
- As of today (June 18, 2025), RYTM TTM EBITDA is -$146.32 million, with the most recent change of +$92.29 million (+38.68%) on March 31, 2025.
- Over the past year, RYTM TTM EBITDA has increased by +$109.22 million (+42.74%).
- RYTM TTM EBITDA is now -2206.15% below its all-time high of -$6.34 million, reached on September 30, 2016.
Performance
RYTM TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
RYTM EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -41.3% | +67.9% | +42.7% |
| 3 y3 years | -247.8% | +16.8% | +21.7% |
| 5 y5 years | -64.0% | -24.2% | +2.5% |
RYTM EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -247.8% | at low | -62.9% | +67.9% | at high | +42.7% |
| 5 y | 5-year | -247.8% | at low | -62.9% | +67.9% | -10.5% | +42.7% |
| alltime | all time | -2151.9% | at low | -588.6% | +67.9% | -2206.2% | +42.7% |
RYTM EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$43.63M(+16.2%) | -$146.32M(-38.7%) |
| Dec 2024 | -$238.09M(+41.3%) | -$37.55M(-2.1%) | -$238.61M(+0.5%) |
| Sep 2024 | - | -$38.36M(+43.2%) | -$237.53M(-0.8%) |
| Jun 2024 | - | -$26.79M(-80.3%) | -$239.38M(-6.3%) |
| Mar 2024 | - | -$135.91M(+272.7%) | -$255.54M(+51.8%) |
| Dec 2023 | -$168.46M(-3.3%) | -$36.47M(-9.3%) | -$168.29M(-1.5%) |
| Sep 2023 | - | -$40.20M(-6.4%) | -$170.86M(+1.1%) |
| Jun 2023 | - | -$42.96M(-11.7%) | -$168.93M(-0.9%) |
| Mar 2023 | - | -$48.66M(+24.6%) | -$170.49M(-2.2%) |
| Dec 2022 | -$174.25M(+154.5%) | -$39.04M(+2.0%) | -$174.25M(-6.2%) |
| Sep 2022 | - | -$38.27M(-14.0%) | -$185.74M(-2.9%) |
| Jun 2022 | - | -$44.52M(-15.1%) | -$191.25M(+2.4%) |
| Mar 2022 | - | -$52.41M(+3.7%) | -$186.85M(+10.8%) |
| Dec 2021 | -$68.45M(-48.6%) | -$50.53M(+15.4%) | -$168.63M(+12.1%) |
| Sep 2021 | - | -$43.79M(+9.2%) | -$150.41M(+6.9%) |
| Jun 2021 | - | -$40.12M(+17.3%) | -$140.74M(+6.3%) |
| Mar 2021 | - | -$34.20M(+5.8%) | -$132.37M(-0.7%) |
| Dec 2020 | -$133.31M | -$32.32M(-5.3%) | -$133.31M(-1.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$34.11M(+7.5%) | -$135.02M(-2.0%) |
| Jun 2020 | - | -$31.75M(-9.6%) | -$137.83M(-8.1%) |
| Mar 2020 | - | -$35.13M(+3.2%) | -$150.02M(+3.3%) |
| Dec 2019 | -$145.17M(+86.2%) | -$34.03M(-7.8%) | -$145.17M(+5.1%) |
| Sep 2019 | - | -$36.92M(-16.0%) | -$138.07M(+14.8%) |
| Jun 2019 | - | -$43.94M(+45.1%) | -$120.29M(+31.7%) |
| Mar 2019 | - | -$30.27M(+12.4%) | -$91.31M(+17.1%) |
| Dec 2018 | -$77.97M(+142.2%) | -$26.94M(+40.8%) | -$77.97M(+25.8%) |
| Sep 2018 | - | -$19.14M(+27.9%) | -$61.96M(+21.4%) |
| Jun 2018 | - | -$14.96M(-11.7%) | -$51.05M(+19.3%) |
| Mar 2018 | - | -$16.94M(+55.1%) | -$42.79M(+32.9%) |
| Dec 2017 | -$32.19M(+25.0%) | -$10.92M(+32.7%) | -$32.19M(+8.8%) |
| Sep 2017 | - | -$8.23M(+22.9%) | -$29.59M(+6.8%) |
| Jun 2017 | - | -$6.70M(+5.8%) | -$27.70M(+31.9%) |
| Mar 2017 | - | -$6.33M(-23.9%) | -$21.00M(+43.2%) |
| Dec 2016 | -$25.76M(+143.6%) | -$8.32M(+31.1%) | -$14.66M(+131.1%) |
| Sep 2016 | - | -$6.34M | -$6.34M |
| Dec 2015 | -$10.57M | - | - |
FAQ
- What is Rhythm Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals annual EBITDA year-on-year change?
- What is Rhythm Pharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Rhythm Pharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals TTM EBITDA year-on-year change?
What is Rhythm Pharmaceuticals annual EBITDA?
The current annual EBITDA of RYTM is -$238.09M
What is the all time high annual EBITDA for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high annual EBITDA is -$10.57M
What is Rhythm Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, RYTM annual EBITDA has changed by -$69.63M (-41.33%)
What is Rhythm Pharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of RYTM is -$43.63M
What is the all time high quarterly EBITDA for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high quarterly EBITDA is -$6.33M
What is Rhythm Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, RYTM quarterly EBITDA has changed by +$92.29M (+67.90%)
What is Rhythm Pharmaceuticals TTM EBITDA?
The current TTM EBITDA of RYTM is -$146.32M
What is the all time high TTM EBITDA for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high TTM EBITDA is -$6.34M
What is Rhythm Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, RYTM TTM EBITDA has changed by +$109.22M (+42.74%)